Literature DB >> 16216327

Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitope.

Philip J Norris1, Jennifer D Stone, Nadezhda Anikeeva, John W Heitman, Ingrid C Wilson, Dale F Hirschkorn, Margaret J Clark, Howell F Moffett, Thomas O Cameron, Yuri Sykulev, Lawrence J Stern, Bruce D Walker.   

Abstract

Antagonism of T cell responses by variants of the cognate peptide is a potential mechanism of viral escape from immune responses and may play a role in the ability of HIV to evade immune control. We show here a rarely described mechanism of antagonism by a peptide shorter than the minimum length epitope for an HIV p24-specific CD4+ T cell clone. The shorter antagonist peptide-MHC complex bound the T cell receptor (TCR), albeit with lower affinity than the full-length agonist peptide. Prior work showing the crystal structure of the peptide-MHC complex revealed a unique glycine hinge near the C-terminus of the agonist peptide, allowing the generation of full-length antagonist peptide lacking the hinge. These results confirm the dependence of productive TCR engagement on residues spilling out from the C-terminus of the MHC binding groove and show that partial engagement of the TCR with a truncated, low-affinity ligand can result in T cell antagonism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216327      PMCID: PMC2561961          DOI: 10.1016/j.molimm.2005.09.004

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  53 in total

1.  Study of the mechanism of TCR antagonism using dual-TCR-expressing T cells.

Authors:  Wen Yang; Howard M Grey
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

2.  A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition.

Authors:  Zarixia Zavala-Ruiz; Iwona Strug; Bruce D Walker; Philip J Norris; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-26       Impact factor: 11.205

3.  Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor.

Authors:  M T De Magistris; J Alexander; M Coggeshall; A Altman; F C Gaeta; H M Grey; A Sette
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

4.  Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion.

Authors:  R F Siliciano; T Lawton; C Knall; R W Karr; P Berman; T Gregory; E L Reinherz
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

5.  Functional consequences of engagement of the T cell receptor by low affinity ligands.

Authors:  J Alexander; K Snoke; J Ruppert; J Sidney; M Wall; S Southwood; C Oseroff; T Arrhenius; F C Gaeta; S M Colón
Journal:  J Immunol       Date:  1993-01-01       Impact factor: 5.422

6.  T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues.

Authors:  D Ostrov; J Krieger; J Sidney; A Sette; P Concannon
Journal:  J Immunol       Date:  1993-05-15       Impact factor: 5.422

7.  A peptide that antagonizes TCR-mediated reactions with both syngeneic and allogeneic agonists: functional and structural aspects.

Authors:  Markus G Rudolph; Lucy Q Shen; Stephen A Lamontagne; John G Luz; Joseph R Delaney; Qing Ge; Bryan K Cho; Deborah Palliser; Carol A McKinley; Jianzhu Chen; Ian A Wilson; Herman N Eisen
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

8.  Regulation of the immune response to peptide antigens: differential induction of immediate-type hypersensitivity and T cell proliferation due to changes in either peptide structure or major histocompatibility complex haplotype.

Authors:  P Soloway; S Fish; H Passmore; M Gefter; R Coffee; T Manser
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

9.  T cell receptor antagonism interferes with MHC clustering and integrin patterning during immunological synapse formation.

Authors:  Cenk Sumen; Michael L Dustin; Mark M Davis
Journal:  J Cell Biol       Date:  2004-08-16       Impact factor: 10.539

10.  Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.

Authors:  L Racioppi; F Ronchese; L A Matis; R N Germain
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more
  10 in total

1.  High-affinity T cell receptor differentiates cognate peptide-MHC and altered peptide ligands with distinct kinetics and thermodynamics.

Authors:  Stephen P Persaud; David L Donermeyer; K Scott Weber; David M Kranz; Paul M Allen
Journal:  Mol Immunol       Date:  2010-03-23       Impact factor: 4.407

2.  HIV viral diversity and escape from cellular immunity.

Authors:  Nicole Frahm; Christian Brander
Journal:  Curr Infect Dis Rep       Date:  2007-03       Impact factor: 3.725

3.  Naturally occurring CD4+ T-cell epitope variants act as altered peptide ligands leading to impaired helper T-cell responses in hepatitis C virus infection.

Authors:  Matthew F Cusick; Meiying Yang; Joan C Gill; David D Eckels
Journal:  Hum Immunol       Date:  2011-03-04       Impact factor: 2.850

4.  CD4+ T-cell engagement by both wild-type and variant HCV peptides modulates the conversion of viral clearing helper T cells to Tregs.

Authors:  Matthew F Cusick; Jane E Libbey; Joan Cox Gill; Robert S Fujinami; David D Eckels
Journal:  Future Virol       Date:  2013-07       Impact factor: 1.831

5.  A unique unresponsive CD4+ T cell phenotype post TCR antagonism.

Authors:  Lindsay J Edwards; Brian D Evavold
Journal:  Cell Immunol       Date:  2009-12-23       Impact factor: 4.868

6.  Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection.

Authors:  Leonard Moise; Frances Terry; Andres H Gutierrez; Ryan Tassone; Phyllis Losikoff; Stephen H Gregory; Chris Bailey-Kellogg; William D Martin; Anne S De Groot
Journal:  Front Microbiol       Date:  2014-10-06       Impact factor: 5.640

Review 7.  On Peptides and Altered Peptide Ligands: From Origin, Mode of Action and Design to Clinical Application (Immunotherapy).

Authors:  Martín Candia; Bernhard Kratzer; Winfried F Pickl
Journal:  Int Arch Allergy Immunol       Date:  2016-09-20       Impact factor: 2.749

Review 8.  Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.

Authors:  Pablo A González; Leandro J Carreño; Pablo F Céspedes; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Clin Dev Immunol       Date:  2013-03-07

9.  A CD4+ T cell antagonist epitope down-regulates activating signaling proteins, up-regulates inhibitory signaling proteins and abrogates HIV-specific T cell function.

Authors:  Evan S Jacobs; Desmond Persad; Longsi Ran; Ali Danesh; John W Heitman; Xutao Deng; Mark J Cameron; David J Kelvin; Philip J Norris
Journal:  Retrovirology       Date:  2014-07-05       Impact factor: 4.602

10.  Novel Nested Peptide Epitopes Recognized by CD4+ T Cells Induced by HIV-1 Conserved-Region Vaccines.

Authors:  Nicola Borthwick; Sandra Silva-Arrieta; Anuska Llano; Masafumi Takiguchi; Christian Brander; Tomáš Hanke
Journal:  Vaccines (Basel)       Date:  2020-01-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.